Bibliographie - 4102 - Stabilis 4.0

Seneste opdatering :
19/11/2024

Bibliografi 4102

Type :

Journal

forskerhold :

Auckland - Faculty of Medical and Health Sciences, University of Auckland

Forfattere :

Svirskis D, Behera S, Naidoo N, Beachman J, Raina T, Zhou Y, Berkahn L, Costello I, Gu Y.

Titel :

Stability of vincristine sulfate, doxorubicin hydrochloride and etoposide phosphate admixtures in polyisoprene elastromeric pump supporting transition of the EPOCH regimen to oupatient care.

Nummer :

J Oncol Pharm Practice ;25,4:831-840. 2018

cotationvaleur :

fysisk stabilitet :

kemisk stabilitet :

High Performance Liquid Chromatography - diodearraydetektor (HPLC-DAD)

Stabilitet defineres som 95% af den oprindelige koncentration

andre metoder :

Kommentarer :

Lister

Doxorubicin hydrochloride

Etoposide phosphate

Vincristine sulfate

2-6°C

Vincristine sulfate	0,005 mg/ml
Doxorubicin hydrochloride	0,12 mg/ml
Etoposide phosphate	0,6 mg/ml

2-6°C

Vincristine sulfate	0,01 mg/ml
Doxorubicin hydrochloride	0,24 mg/ml
Etoposide phosphate	1,2 mg/ml

2-6°C

Vincristine sulfate	0,016 mg/ml
Doxorubicin hydrochloride	0,4 mg/ml
Etoposide phosphate	2 mg/ml

35°C

Vincristine sulfate	0,005 mg/ml
Doxorubicin hydrochloride	0,12 mg/ml
Etoposide phosphate	0,6 mg/ml

35°C

Vincristine sulfate	0,01 mg/ml
Doxorubicin hydrochloride	0,24 mg/ml
Etoposide phosphate	1,2 mg/ml

35°C

Vincristine sulfate	0,016 mg/ml
Doxorubicin hydrochloride	0,4 mg/ml
Etoposide phosphate	2 mg/ml

Mentions Légales